Brief: Immunovia Provides Update In Response To COVID-19 Pandemic

Immunovia AB (publ)

01/04/2020 15:07

April 1 (Reuters) - Immunovia AB (publ)  IMMNOV.ST :
    * IMMUNOVIA TAKES ACTION DURING COVID-19 PANDEMIC AND
REMAINS
FOCUSED ON LAUNCH OF IMMRAY ™  PANCAN-D
    * IS TAKING PROACTIVE STEPS TO PROTECT AND LIMIT EXPOSURE OF
OUR
PERSONNEL.
    * INVENTORIES OF CRITICAL CONSUMABLES HAVE BEEN SECURED TO
ENABLE
UNINTERRUPTED CONTINUATION OF OUR COMMERCIALIZATION START
    * RESEARCH AND DEVELOPMENT LABORATORIES AND CLINICAL
LABORATORY,
IN LUND, AS WELL AS PRODUCTION FACILITIES REMAIN OPERATIONAL AT
THIS TIME.
    * INTERIM ANALYSIS OF PANFAM-1 MAY BE POSTPONED TO Q1/Q2
2021,
DEPENDING ON DEVELOPMENT OF COVID-19 PANDEMIC SITUATION
    * IF QUARANTINE IS EXTENDED TO END OF APRIL OR EVEN FURTHER,
THERE
MAY BE ADDITION IMPACTS ON COMPLETION OF THESE PLANS
    * TARGETING AN INITIAL ADDRESSABLE MARKET OF USD 4.4 BILLION
IN US
AND EUROPE,

Source text for Eikon:  ID:nWkr6F3cDw 
Further company coverage:  IMMNOV.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))